NCT03346837View on ClinicalTrials.gov

A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

December 20, 2017

Study Completion Date

December 20, 2017

Conditions
Malignancies Multiple
Interventions
DRUG

BMS-986205

BMS-986205

DRUG

Itraconazole

Oral solution

DRUG

Rifampin

Tablet

Trial Locations (1)

78744

PPD, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03346837 - A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects | Biotech Hunter | Biotech Hunter